Jackson, Grant Investment Advisers, Inc. Vertex Pharmaceuticals Inc Transaction History
Jackson, Grant Investment Advisers, Inc.
- $246 Million
- Q2 2024
A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 18 shares of VRTX stock, worth $8,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 18
-0.0%
Holding current value
$8,534
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,707Shares Held
226MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$12.7 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.9 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.1 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.56 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.05 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $122B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...